{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69cbcfb74bc3c0b5cea89f0c/6ac3af2ecf16445f8b5dfca9?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk - The SELUTION DeNovo HBR sub-study","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69cbcfb74bc3c0b5cea89f0c/1791209100374-a845eb8d-399f-4ced-b905-4a1fb51c3159.jpeg?height=200","description":"<p>In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Philip Urban discuss the findings of SELUTION DeNovo HBR, comparing SEB versus DES PCI strategies.</p><p> Dr Urban describes the dual-risk profile of the enrolled HBR patients and shares the hypothesis-generating results including 1-year TVF, BARC 3+ bleeding, and NACE rates which favoured the balloon arm – possibly linked to lower use of antiplatelet therapy in SEB-treated patients.</p>","author_name":"EuroIntervention"}